Itamar Medical

Itamar Medical is a medical technology firm that develops and commercializes non-invasive diagnosis and monitoring devices for sleep apnea and other sleep-related illnesses. The company was established in 1997 and is based in Caesarea, Israel.

The WatchPAT system, which is a wrist-worn device that uses peripheral arterial tone (PAT) technology to detect and diagnose sleep apnea, is Itamar Medical's flagship product. The WatchPAT system is a non-invasive alternative to traditional sleep studies that can be utilized in the patient's own home.

Itamar Medical, in addition to the WatchPAT system, provides various other solutions for diagnosing and monitoring sleep apnea and related diseases. These include the EndoPAT system, which assesses cardiovascular risk by measuring endothelial function, and the SleePath system, a cloud-based platform for the care of sleep apnea sufferers.

Itamar Medical has won multiple awards and accolades for its revolutionary technology, including being designated a Red Herring Top 100 Global Firm in 2017 and a Fast Firm Most Revolutionary Company in 2020. They have also gained regulatory certifications from organizations such as the US Food and Drug Administration (FDA) and the European CE Mark for their products.

Itamar Medical's most current financial report, which is publicly available, contains information about the company's financial performance. According to that report, the company's sales in 2020 were $49.7 million, up 16.6% from the previous year. Compared to a net loss of $0.9 million in 2019, the company's net income in 2020 was $6.2 million. As of August 2021, Itamar Medical's market value was roughly $1.3 billion. For the fiscal year 2023, Itamar Medical recorded revenue of about $50.9 million.

Founded: 1997
Headquarters: 9 Halamish St, Caesarea, 3088900, Israel
Website: https://www.itamar-medical.com/global-presence/